Argenx highlights data evaluating vyvgart in neuromuscular autoimmune disease at aanem and mgfa scientific sessions

Long-term clinical trial and real-world data illustrate vyvgart® drives consistent, repeatable and clinically meaningful responses, including minimal symptom expression (mse) in generalized myasthenia gravis (gmg)

ARGX Ratings Summary

ARGX Quant Ranking